Stock VRAX VIRAX BIOLABS GROUP LIMITED
Add to a list

Official Publications Virax Biolabs Group Limited

Equities

VRAX

KYG9495L1251

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 21:00:00 13/02/2026 GMT 		5-day change 1st Jan Change
0.2066 USD -1.20% Intraday chart for Virax Biolabs Group Limited -8.83% -40.25%
12-02 Virax Biolabs Group Limited announced that it expects to receive $5 million in funding CI
12-02 Virax Biolabs Group Limited Reports Earnings Results for the Half Year Ended September 30, 2025 CI

Official Publications

No official publication found

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas
  1. Stock Market
  2. Equities
  3. VRAX Stock
  4. News Virax Biolabs Group Limited
  5. Official Publications

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States
United-States
Canada
Canada

MIDDLE EAST

Saudi Arabia
Saudi Arabia
United Arab Emirates
United Arab Emirates

EUROPE

France
France
Deutschland
Deutschland
Suisse
Suisse
Schweiz
Schweiz
Italia
Italia
Österreich
Österreich
België
België
Nederland
Nederland
España
España
Sverige
Sverige
United Kingdom
United Kingdom

APAC

Australia
Australia
India
India
Hong Kong
Hong Kong
United States

MarketScreener is also available in this country: United States.

Switch edition
Stay in the current country edition